Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 2, 2010, Pages 369-375

  Jung, Chin W ^a   Tan, Jennifer ^b   Tan, Nelly ^c   Kuo, Melissa N ^d   Ashok, Ashwin ^a   Eells, Samantha J ^b   Miller, Loren G ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Harbor UCLA Medical Foundation Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ST MARY MEDICAL CENTER   (United States)

Author keywords

Evaluation; Hepatitis B; Hepatitis B virus; Treatment

Indexed keywords

ADEFOVIR; EMTRICITABINE; HEPATITIS B SURFACE ANTIGEN; INTERFERON; LAMIVUDINE; TENOFOVIR;

ADULT; AFRICAN AMERICAN; ARTICLE; CHRONIC HEPATITIS; DISEASE DURATION; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN TISSUE; IMMIGRANT; LABORATORY TEST; LIVER BIOPSY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; SEX RATIO;

EID: 76149139407     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06023.x     Document Type: Article

References (22)

1. World Health Organization (WHO). Fact sheet WHO/204. Hepatitis B. Cited 16 Oct 2006. Available from URL: http://www.who.int/mediacentre/factsheets/ fs204/en
2. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 : 507 539.
3. Dienstag JL, Schiff ER, Wright TL et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N. Engl. J. Med. 1999 341 : 1256 1263.
4. Marcellin P, Chang TT, Lim SG et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N. Engl. J. Med. 2003 348 : 808 816. (Pubitemid 36245757)
5. Chang TT, Gish RG, de Man R et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N. Engl. J. Med. 2006 354 : 1001 1010.
6. Lau GK, Piratvisuth T, Luo KX et al. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N. Engl. J. Med. 2005 352 : 2682 2695.
7. Liaw YF, Sung JJY, Chow WC et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Engl. J. Med. 2004 351 : 1521 1531.
8. Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999 29 : 971 975.
9. Fung SK, Wong FSH, Wong DKH, Hussain MT, Lok ASF. Hepatitis B virus genotypes, precore and core promoter variants among predominantly Asian patients with chronic HBV infection in a Canadian center. Liver Int. 2006 26 : 796 804.
10. Shire NJ, Sherman KE. Management of HBV/HIV-coinfected patients. Semin. Liver Dis. 2005 25 (Suppl. 1 48 57.
11. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch. Intern. Med. 2003 163 : 49 56.
12. Sueta CA, Chowdhury M, Boccuzzi SJ et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am. J. Cardiol. 1999 83 : 1303 1307.
13. Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J. Gen. Intern. Med. 2005 20 : 754 758.
14. Schelleman H, Klungel OH, Kromhout D, de Boer A, Stricker BH, Verschuren WM. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J. Hum. Hypertens 2004 18 : 317 324.
15. Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J. Gen. Intern. Med. 1999 14 : 711 717.
16. Lok AS, McMahon BJ Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology 2004 39 : 857 861.
17. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008 1 139. Available from URL: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf, Accessed August 22, 2009.
18. Zeiger RS, Heller S, Mellon MH, Wald J, Falkoff R, Schatz M. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J. Allergy Clin. Immunol. 1991 87 : 1160 1168.
19. Bertakis KD, Rahman A, Helms J, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J. Fam. Pract. 2000 49 : 147 152.
20. Redberg RF. Gender, race, and cardiac care: why the differences? J. Am. Coll. Cardiol. 2005 46 : 1852 1854.
21. McLaughlin TJ, Soumerai SB, Willison DJ et al. Adherence to national guidelines for drug treatment of suspected myocardial infarction: evidence for undertreatment in women and the elderly. Arch. Intern. Med. 1996 156 : 799 805.
22. Lok AS, McMahon BJ Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B. Hepatology 2001 34 : 1225 1241.